Literature DB >> 21194832

Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53.

Binghui Li1, Jiong Zhao, Chong-Zhi Wang, Jennifer Searle, Tong-Chuan He, Chun-Su Yuan, Wei Du.   

Abstract

Ginsenosides are the main bioactive components in American ginseng, a commonly used herb. In this study, we showed that the ginsenoside Rh2 exhibited significantly more potent cell death activity than the ginsenoside Rg3 in HCT116 and SW480 colorectal cancer cells. Cell death induced by Rh2 is mediated in part by the caspase-dependent apoptosis and in part by the caspase-independent paraptosis, a type of cell death that is characterized by the accumulation of cytoplasmic vacuoles. Treatment of cells with Rh2 activated the p53 pathway and significantly increased the levels of the pro-apoptotic regulator, Bax, while decreasing the levels of anti-apoptosis regulator Bcl-2. Removal of p53 significantly blocked Rh2-induced cell death as well as vacuole formation, suggesting that both types of cell death induced by Rh2 are mediated by p53 activity. Furthermore, we show that Rh2 increased ROS levels and activated the NF-κB survival pathway. Blockage of ROS by NAC or catalase inhibited the activation of NF-κB signaling and enhanced Rh2-induced cell death, suggesting that the anti-cancer effect of Rh2 can be enhanced by antioxidants. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21194832      PMCID: PMC3022099          DOI: 10.1016/j.canlet.2010.11.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  24 in total

1.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Authors:  Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 2.  Natural products in anticancer therapy.

Authors:  A B da Rocha; R M Lopes; G Schwartsmann
Journal:  Curr Opin Pharmacol       Date:  2001-08       Impact factor: 5.547

Review 3.  The autophagosomal-lysosomal compartment in programmed cell death.

Authors:  W Bursch
Journal:  Cell Death Differ       Date:  2001-06       Impact factor: 15.828

Review 4.  Natural products in cancer chemotherapy: past, present and future.

Authors:  John Mann
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

Review 5.  Developmental cell death: morphological diversity and multiple mechanisms.

Authors:  P G Clarke
Journal:  Anat Embryol (Berl)       Date:  1990

6.  Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities.

Authors:  Eun-Ah Bae; Myung Joo Han; Min-Kyung Choo; Sun-Young Park; Dong-Hyun Kim
Journal:  Biol Pharm Bull       Date:  2002-01       Impact factor: 2.233

Review 7.  Molecular mechanisms of necroptosis: an ordered cellular explosion.

Authors:  Peter Vandenabeele; Lorenzo Galluzzi; Tom Vanden Berghe; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09-08       Impact factor: 94.444

8.  N-Acetylcysteine, vitamin C and vitamin E diminish homocysteine thiolactone-induced apoptosis in human promyeloid HL-60 cells.

Authors:  Rwei-Fen S Huang; Sheu-Mai Huang; Bo-Shiou Lin; Chien-Ya Hung; Hsing-Te Lu
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

9.  Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix.

Authors:  S Sperandio; K Poksay; I de Belle; M J Lafuente; B Liu; J Nasir; D E Bredesen
Journal:  Cell Death Differ       Date:  2004-10       Impact factor: 15.828

10.  An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression.

Authors:  Ying Wang; Xianting Li; Lu Wang; Peiguo Ding; Yingmei Zhang; Wenling Han; Dalong Ma
Journal:  J Cell Sci       Date:  2004-03-15       Impact factor: 5.285

View more
  88 in total

Review 1.  Role of phytochemicals in colorectal cancer prevention.

Authors:  Yu-Hua Li; Yin-Bo Niu; Yang Sun; Feng Zhang; Chang-Xu Liu; Lei Fan; Qi-Bing Mei
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

2.  Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13.

Authors:  Ning Guan; Xiaochuan Huo; Zhenxing Zhang; Shoudan Zhang; Junsheng Luo; Wenshi Guo
Journal:  Tumour Biol       Date:  2015-04-03

3.  Ginseng metabolite protopanaxadiol interferes with lipid metabolism and induces endoplasmic reticulum stress and p53 activation to promote cancer cell death.

Authors:  Hong Ri Jin; Charles H Du; Chong-Zhi Wang; Chun-Su Yuan; Wei Du
Journal:  Phytother Res       Date:  2018-12-09       Impact factor: 5.878

4.  Induction of apoptosis and reversal of permeability glycoprotein-mediated multidrug resistance of MCF-7/ADM by ginsenoside Rh2.

Authors:  Hui Zhang; Jian Gong; Huilai Zhang; Di Kong
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.

Authors:  Kevin M Knopf; Brendan L Murphy; Samantha N MacMillan; Jeremy M Baskin; Martin P Barr; Eszter Boros; Justin J Wilson
Journal:  J Am Chem Soc       Date:  2017-09-26       Impact factor: 15.419

6.  EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2.

Authors:  Shaoyi Li; Yun Gao; Weining Ma; Wenchang Guo; Gang Zhou; Tianci Cheng; Yunhui Liu
Journal:  Tumour Biol       Date:  2014-02-21

7.  Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.

Authors:  Xi-Ping Tang; Guo-Du Tang; Chun-Yun Fang; Zhi-Hai Liang; Lu-Yi Zhang
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

8.  Ginsenoside Rh2 alleviates tumor-associated depression in a mouse model of colorectal carcinoma.

Authors:  Jia Wang; Yueming Chen; Chunxiao Dai; Yushan Shang; Jian Xie
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

9.  Ginsenoside Rh2 inhibits invasiveness of glioblastoma through modulation of VEGF-A.

Authors:  Shaoyi Li; Yun Gao; Weining Ma; Tianci Cheng; Yunhui Liu
Journal:  Tumour Biol       Date:  2015-07-29

10.  The antitumor activity study of ginsenosides and metabolites in lung cancer cell.

Authors:  Feng-Yuan Xu; Wen-Qing Shang; Jia-Jun Yu; Qian Sun; Ming-Qing Li; Jian-Song Sun
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.